Hantz Financial Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Hantz Financial Services’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390K	Sell	26,889 -14,443	-35%	-$195K	0.01%	824
2026 Q1	$572K	Buy	41,332 +2,532	+7%	+$35.2K	0.01%	616
2025 Q4	$545K	Buy	38,800 +8,185	+27%	+$115K	0.01%	590
2025 Q3	$428K	Buy	30,615 +18,934	+162%	+$272K	0.01%	581
2025 Q2	$176K	Buy	11,681 +11,190	+2,279%	+$160K	﹤0.01%	635
2025 Q1	$6K	Buy	+491	New	+$6.78K	﹤0.01%	1123

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hantz Financial Services's RDY Position: Q2 2026 in Review

Hantz Financial Services reduced its Dr. Reddy's Laboratories (RDY) stake by 35% in Q2 2026, selling an estimated $195K and leaving 26,889 shares worth $390K. The position accounts for 0.01% of the portfolio, ranked #824.

Hantz Financial Services first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. The position peaked at $572K in Q1 2026. 226 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Hantz Financial Services held 26,889 shares of Dr. Reddy's Laboratories worth $390K as of Q2 2026.
Hantz Financial Services sold 14,443 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $195K.
Dr. Reddy's Laboratories made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #824 holding.
Hantz Financial Services first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
Hantz Financial Services's Dr. Reddy's Laboratories position peaked at $572K in Q1 2026.
226 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.